Product image of Methyldopa Pharmapoint Uk (Methyldopa) supplied by GNH India

Methyldopa Pharmapoint Uk

Active Ingredient:
Methyldopa
Origin:
EU

Methyldopa Pharmapoint Uk (Methyldopa)

Methyldopa, the active ingredient in Methyldopa Pharmapoint Uk, is an Alpha-2 adrenergic agonist presented as an oral formulation for oral use. It reduces sympathetic outflow by stimulating central alpha‑2 receptors, thereby achieving sustained blood pressure control in adults with hypertension, including pregnancy‑induced hypertension. The medication is indicated for long‑term management and is administered under physician supervision.

GNH India supplies Methyldopa Pharmapoint Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is manufactured under strict GMP conditions.

Manufacturer / TM Owner

Pharmapoint Uk Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Methyldopa is used to manage conditions within the hypertension disease family by modulating central sympathetic activity.
  • Hypertension: reduces elevated systemic blood pressure in essential hypertension.
  • Pregnancy‑induced hypertension: controls blood pressure in gestational hypertension to protect maternal and fetal health.
  • Chronic hypertension: maintains target blood pressure levels for long‑term cardiovascular risk reduction.
  • Mild pre‑eclampsia: helps lower blood pressure as part of a broader therapeutic regimen.

How It Works

  • After oral absorption, methyldopa is converted to alpha‑methyldopa, which acts as an agonist at central alpha‑2 adrenergic receptors in the medulla. Stimulation of these receptors decreases sympathetic outflow, leading to reduced peripheral vascular resistance and lowered cardiac output, thereby producing a sustained antihypertensive effect.

Side Effects

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dry mouth: reduced salivation causing discomfort.
  • Headache: mild to moderate head pain.
  • Dizziness: light‑headed sensation upon standing.

Serious or Rare Side Effects

  • Liver dysfunction: elevated liver enzymes or hepatitis.
  • Hemolytic anemia: destruction of red blood cells.
  • Severe hypotension: sudden, marked drop in blood pressure.

Precautions & Warnings

Methyldopa should be used with careful clinical monitoring.

  • Monitor blood pressure: adjust therapy based on regular measurements.
  • Assess liver function: periodic liver enzyme testing is recommended.
  • Evaluate for anemia: watch for signs of hemolysis or reduced hemoglobin.
  • Use caution in cardiac disease: patients with ischemic heart disease may need additional monitoring.
  • Avoid abrupt discontinuation: taper under medical guidance to prevent rebound hypertension.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Methyldopa may interact with several drug classes.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis.
  • Beta‑blockers: additive hypotensive effect.
  • Clonidine: excessive fall in blood pressure when combined.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may reduce antihypertensive efficacy.
  • Lithium: increased lithium levels, monitor serum concentration.

Frequently Asked Questions

Methyldopa Pharmapoint Uk is prescribed to lower high blood pressure in adults. It is indicated for essential hypertension and for managing hypertension that develops during pregnancy, helping to protect both maternal and fetal health by maintaining safer blood pressure levels.

After ingestion, methyldopa is converted to alpha‑methyldopa, which stimulates central alpha‑2 adrenergic receptors in the brainstem. This activation reduces sympathetic nervous system outflow, leading to decreased peripheral vascular resistance and lower cardiac output, which together lower systemic blood pressure.

The appropriate dose of methyldopa is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other medications. Patients should follow the specific dosing instructions provided by their healthcare professional and not adjust the dose on their own.

Methyldopa is one of the antihypertensive agents that may be used during pregnancy when blood pressure control is needed, although its pregnancy category is listed as unknown. It should only be used under close medical supervision. Limited data are available for breastfeeding, so a physician should evaluate the risk‑benefit balance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Methyldopa belongs to the alpha‑2 adrenergic agonist class, whereas many alternatives such as beta‑blockers, calcium‑channel blockers, or ACE inhibitors act on different pathways. Methyldopa is often chosen for pregnancy‑related hypertension because of its long safety record, but it may cause more central nervous system side effects compared with some newer agents.

Store the product at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children. Do not use the medication after the expiry date printed on the label.

Methyldopa is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Patients should swallow the tablets whole and not crush or chew them unless specifically instructed by a healthcare professional.

The most serious adverse reactions include severe hypotension (dangerously low blood pressure), liver dysfunction such as hepatitis, and hemolytic anemia where red blood cells are destroyed. Any sudden weakness, jaundice, dark urine, or unexplained fatigue should prompt immediate medical evaluation.

Methyldopa should be avoided in individuals with known hypersensitivity to the drug or its excipients, those with severe liver disease, and patients who have experienced a previous episode of hemolytic anemia while on the medication. It is also contraindicated in patients with certain cardiac conditions where a rapid drop in blood pressure could be hazardous.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.